Skip to main content

IMOVAX POLIO

Product overview

Type
Polio Vaccine - Inactivated (IPV)
Commercial Name
IMOVAX POLIO
Manufacturer
Sanofi Pasteur
Responsible NRA
Agence nationale de sécurité du médicament et des produits de santé
Country
France

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
10
Diluent
Not Applicable
Route of Administration
Intramuscular or Subcutaneous
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 7
Secondary Packaging
Carton of 10 vials (100 doses) [Dimensions: 10.6 x 4.7 x 4.9]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
2-phenoxyethanol
Vaccine Preservative Concentration
5 mg/mL
Cold Chain Volume
2.44 cm3/dose (in secondary packaging)

Attachments

VPSAR (Vaccine Public Summary Assessment Report)